HCA Healthcare Stock-Based Comp decreased by 14.0% to $86.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 12.2%, from $98.00M to $86.00M. Over 4 years (FY 2021 to FY 2025), Stock-Based Comp shows relatively stable performance with a -2.3% CAGR.
An increase may signal a strategy to preserve cash or align employee interests with shareholders, but it also results in share dilution.
Stock-based compensation is a non-cash expense where employees and executives are rewarded with equity or stock options...
High-growth technology firms often have higher stock-based compensation as a percentage of revenue compared to mature industrial firms.
cf_stock_based_compensation| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $129.00M | $115.00M | $99.00M | $86.00M | $85.00M | $87.00M | $83.00M | $77.00M | $56.00M | $72.00M | $57.00M | $87.00M | $112.00M | $76.00M | $85.00M | $98.00M | $99.00M | $104.00M | $100.00M | $86.00M |
| QoQ Change | — | -10.9% | -13.9% | -13.1% | -1.2% | +2.4% | -4.6% | -7.2% | -27.3% | +28.6% | -20.8% | +52.6% | +28.7% | -32.1% | +11.8% | +15.3% | +1.0% | +5.1% | -3.8% | -14.0% |
| YoY Change | — | — | — | — | -34.1% | -24.3% | -16.2% | -10.5% | -34.1% | -17.2% | -31.3% | +13.0% | +100.0% | +5.6% | +49.1% | +12.6% | -11.6% | +36.8% | +17.6% | -12.2% |